| Host: |
Rabbit |
| Applications: |
WB/IHC/IF/ELISA |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Cyclin-dependent kinase inhibitor 3 (31-80 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300ELISA 1:20000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
CDKN3 |
| Gene ID: |
1033 |
| Uniprot ID: |
CDKN3_HUMAN |
| Immunogen Region: |
31-80 aa |
| Specificity: |
CDKN3 Polyclonal Antibody detects endogenous levels of CDKN3 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human CDKN3 at the amino acid range 31-80 |
| Protein Name | Cyclin-Dependent Kinase Inhibitor 3Cdk2-Associated Dual-Specificity PhosphataseCyclin-Dependent Kinase Interactor 1Cyclin-Dependent Kinase-Interacting Protein 2Kinase-Associated Phosphatase |
| Cellular Localisation | CytoplasmPerinuclear Region |
| Alternative Antibody Names | Anti-Cyclin-Dependent Kinase Inhibitor 3 antibodyAnti-Cdk2-Associated Dual-Specificity Phosphatase antibodyAnti-Cyclin-Dependent Kinase Interactor 1 antibodyAnti-Cyclin-Dependent Kinase-Interacting Protein 2 antibodyAnti-Kinase-Associated Phosphatase antibodyAnti-CDKN3 antibodyAnti-CDI1 antibodyAnti-CIP2 antibodyAnti-KAP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
